Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Harmonization of measurement strategies for exposure to manufactured nano-objects; report of a workshop.
Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance.
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy.
See All 3 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy.
Chibaya L, Snyder J, Ruscetti M. Senescence and the tumor-immune landscape: Implications for cancer immunotherapy. Semin Cancer Biol. 2022 11; 86(Pt 3):827-845.
View in:
PubMed
subject areas
Cellular Senescence
Humans
Immunotherapy
Neoplasms
Phenotype
Tumor Microenvironment
authors with profiles
Marcus Ruscetti PhD